Rubén Lamich
Impact in
- Genetics top 5%
- Mesenchymal stem cell research
-
- Electrospun Nanofibers in Biomedical Applications
Papers in
- Co-authors
- Fernando Figueroa (6 shared papers)Carolina Nazzal (4 shared papers)Jorge Bartolucci (5 shared papers)Maroun Khoury (4 shared papers)Fernando Verdugo (6 shared papers)Ricardo Larrea (3 shared papers)Ema Abarzúa (3 shared papers)Francisca Alcayaga‐Miranda (1 shared paper)
- Journals
- Journal of the American College of Cardiology (2 papers)Cytotherapy (1 paper)European Heart Journal (1 paper)American Heart Journal (1 paper)Circulation Research (1 paper)
- Partner nations
- ChileSpainUnited States
In The Last Decade
Rubén Lamich
14 papers receiving 430 citations
Rubén Lamich's Hit Papers
Peers
Comparison fields: 5 of 50
- Genetics 209
- Biomaterials 70
- Surgery 202
- Transplantation 12
- Cardiology and Cardiovascular Medicine 52
Countries citing papers authored by Rubén Lamich
This map shows the geographic impact of Rubén Lamich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rubén Lamich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rubén Lamich more than expected).
Fields of papers citing papers by Rubén Lamich
This network shows the impact of papers produced by Rubén Lamich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rubén Lamich. The network helps show where Rubén Lamich may publish in the future.
Co-authors
The 25 scholars most cited alongside Rubén Lamich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure Hit paper breakdown → | 2017 | 348 |
| 2 | 1998 | 37 | |
| 3 | 1997 | 24 | |
| 4 | 2015 | 5 | |
| 5 | 1993 | 4 | |
| 6 | [Coronary stent placement for recurrent angina secondary to myocardial bridging]. | 1998 | 3 |
| 7 | 2008 | 3 | |
| 8 | 1995 | 2 | |
| 9 | 2013 | 2 | |
| 10 | 2010 | 2 | |
| 11 | 2014 | 2 | |
| 12 | 2013 | 2 | |
| 13 | 2011 | 2 | |
| 14 | Phase 1/2 randomized clinical trial of intravenous infusion of umbilical cord mesenchymal stem cells in patients with chronic cardiopathy with stable heart failure (RIMECARD) | 2016 | 1 |
About Rubén Lamich
Rubén Lamich is a scholar working on Surgery, Genetics, Cardiology and Cardiovascular Medicine, Biomedical Engineering and Pharmacology, having authored 14 papers that have together received 437 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (5 papers), Cardiac Structural Anomalies and Repair (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Mechanical Circulatory Support Devices (2 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper), Electrospun Nanofibers in Biomedical Applications (1 paper), Infective Endocarditis Diagnosis and Management (1 paper) and Acute Myocardial Infarction Research (1 paper). The work is most often cited by research in Genetics (209 citations), Biomaterials (70 citations), Surgery (202 citations), Transplantation (12 citations) and Cardiology and Cardiovascular Medicine (52 citations). Rubén Lamich has collaborated with scholars based in Chile, Spain and United States. Frequent co-authors include Fernando Figueroa, Carolina Nazzal, Jorge Bartolucci, Maroun Khoury, Fernando Verdugo, Ricardo Larrea, Ema Abarzúa, Francisca Alcayaga‐Miranda, Jimena Cuenca and Matthew Brobeck. Their work appears in journals such as Journal of the American College of Cardiology, Cytotherapy, European Heart Journal, American Heart Journal and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.